ID   M3K1_RAT                Reviewed;        1493 AA.
AC   Q62925;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   07-APR-2021, entry version 166.
DE   RecName: Full=Mitogen-activated protein kinase kinase kinase 1;
DE            EC=2.7.11.25;
DE   AltName: Full=MAPK/ERK kinase kinase 1;
DE            Short=MEK kinase 1;
DE            Short=MEKK 1;
GN   Name=Map3k1; Synonyms=Mekk, Mekk1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], SUBCELLULAR LOCATION, AND MUTAGENESIS OF
RP   ASP-1369.
RC   TISSUE=Brain;
RX   PubMed=8643568; DOI=10.1073/pnas.93.11.5291;
RA   Xu S., Robbins D.J., Christerson L.B., English J.M., Vanderbilt C.A.,
RA   Cobb M.H.;
RT   "Cloning of rat MEK kinase 1 cDNA reveals an endogenous membrane-associated
RT   195-kDa protein with a large regulatory domain.";
RL   Proc. Natl. Acad. Sci. U.S.A. 93:5291-5295(1996).
RN   [2]
RP   FUNCTION, ACTIVITY REGULATION, OLIGOMERIZATION, PHOSPHORYLATION AT THR-1381
RP   AND THR-1393, AND MUTAGENESIS OF ASP-1350; THR-1381 AND THR-1393.
RX   PubMed=11784851; DOI=10.1128/mcb.22.3.737-749.2002;
RA   Chadee D.N., Yuasa T., Kyriakis J.M.;
RT   "Direct activation of mitogen-activated protein kinase kinase kinase MEKK1
RT   by the Ste20p homologue GCK and the adapter protein TRAF2.";
RL   Mol. Cell. Biol. 22:737-749(2002).
RN   [3]
RP   INTERACTION WITH GRIPAP1.
RX   PubMed=17761173; DOI=10.1016/j.febslet.2007.08.008;
RA   Ye B., Yu W.P., Thomas G.M., Huganir R.L.;
RT   "GRASP-1 is a neuronal scaffold protein for the JNK signaling pathway.";
RL   FEBS Lett. 581:4403-4410(2007).
RN   [4]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-137 AND SER-910, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Component of a protein kinase signal transduction cascade
CC       (PubMed:11784851). Activates the ERK and JNK kinase pathways by
CC       phosphorylation of MAP2K1 and MAP2K4 (PubMed:11784851). May
CC       phosphorylate the MAPK8/JNK1 kinase (By similarity). Activates CHUK and
CC       IKBKB, the central protein kinases of the NF-kappa-B pathway
CC       (PubMed:11784851). {ECO:0000250|UniProtKB:P53349,
CC       ECO:0000269|PubMed:11784851}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.25;
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.25;
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC   -!- ACTIVITY REGULATION: Activated by autophosphorylation on Thr-1381 and
CC       Thr-1393 following oligomerization. {ECO:0000269|PubMed:11784851}.
CC   -!- SUBUNIT: Binds both upstream activators and downstream substrates in
CC       multimolecular complexes through its N-terminus. Oligomerizes after
CC       binding MAP4K2 or TRAF2. Interacts (via the kinase catalytic domain)
CC       with STK38 (By similarity). Interacts with GRIPAP1 (PubMed:17761173).
CC       {ECO:0000250|UniProtKB:Q13233, ECO:0000269|PubMed:17761173}.
CC   -!- INTERACTION:
CC       Q62925; Q12933: TRAF2; Xeno; NbExp=2; IntAct=EBI-636664, EBI-355744;
CC       Q62925; P61088: UBE2N; Xeno; NbExp=46; IntAct=EBI-636664, EBI-1052908;
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:8643568}; Peripheral
CC       membrane protein {ECO:0000269|PubMed:8643568}.
CC   -!- TISSUE SPECIFICITY: Most highly expressed in spleen, kidney and lung.
CC   -!- PTM: Autophosphorylated. {ECO:0000269|PubMed:11784851}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. STE Ser/Thr
CC       protein kinase family. MAP kinase kinase kinase subfamily.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U48596; AAC52596.1; -; mRNA.
DR   PIR; T10757; T10757.
DR   RefSeq; NP_446339.1; NM_053887.1.
DR   SMR; Q62925; -.
DR   BioGRID; 250551; 1.
DR   IntAct; Q62925; 85.
DR   MINT; Q62925; -.
DR   STRING; 10116.ENSRNOP00000017968; -.
DR   iPTMnet; Q62925; -.
DR   PhosphoSitePlus; Q62925; -.
DR   PaxDb; Q62925; -.
DR   PRIDE; Q62925; -.
DR   GeneID; 116667; -.
DR   KEGG; rno:116667; -.
DR   CTD; 4214; -.
DR   RGD; 620966; Map3k1.
DR   eggNOG; KOG0198; Eukaryota.
DR   InParanoid; Q62925; -.
DR   OrthoDB; 797346at2759; -.
DR   PhylomeDB; Q62925; -.
DR   BRENDA; 2.7.12.2; 5301.
DR   Reactome; R-RNO-166058; MyD88:MAL(TIRAP) cascade initiated on plasma membrane.
DR   Reactome; R-RNO-2871796; FCERI mediated MAPK activation.
DR   Reactome; R-RNO-975138; TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation.
DR   Reactome; R-RNO-975871; MyD88 cascade initiated on plasma membrane.
DR   PRO; PR:Q62925; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005737; C:cytoplasm; IDA:RGD.
DR   GO; GO:0031941; C:filamentous actin; ISO:RGD.
DR   GO; GO:0016020; C:membrane; IDA:RGD.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0008092; F:cytoskeletal protein binding; ISO:RGD.
DR   GO; GO:0008432; F:JUN kinase binding; IPI:RGD.
DR   GO; GO:0004706; F:JUN kinase kinase kinase activity; IDA:RGD.
DR   GO; GO:0004709; F:MAP kinase kinase kinase activity; IDA:RGD.
DR   GO; GO:0051019; F:mitogen-activated protein kinase binding; IPI:RGD.
DR   GO; GO:0031434; F:mitogen-activated protein kinase kinase binding; IPI:RGD.
DR   GO; GO:0004672; F:protein kinase activity; ISO:RGD.
DR   GO; GO:0019901; F:protein kinase binding; ISO:RGD.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; ISO:RGD.
DR   GO; GO:0106311; F:protein threonine kinase activity; IEA:RHEA.
DR   GO; GO:0044877; F:protein-containing complex binding; IDA:RGD.
DR   GO; GO:0046625; F:sphingolipid binding; IPI:RGD.
DR   GO; GO:0004842; F:ubiquitin-protein transferase activity; IMP:RGD.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0007256; P:activation of JNKK activity; IDA:RGD.
DR   GO; GO:0007257; P:activation of JUN kinase activity; ISO:RGD.
DR   GO; GO:0000186; P:activation of MAPKK activity; IDA:RGD.
DR   GO; GO:0008637; P:apoptotic mitochondrial changes; ISO:RGD.
DR   GO; GO:0043010; P:camera-type eye development; ISO:RGD.
DR   GO; GO:0071260; P:cellular response to mechanical stimulus; ISO:RGD.
DR   GO; GO:0003382; P:epithelial cell morphogenesis; ISO:RGD.
DR   GO; GO:0061029; P:eyelid development in camera-type eye; ISO:RGD.
DR   GO; GO:0007254; P:JNK cascade; ISO:RGD.
DR   GO; GO:0000165; P:MAPK cascade; IDA:RGD.
DR   GO; GO:0002011; P:morphogenesis of an epithelial sheet; ISO:RGD.
DR   GO; GO:0032232; P:negative regulation of actin filament bundle assembly; IDA:RGD.
DR   GO; GO:0018105; P:peptidyl-serine phosphorylation; IDA:RGD.
DR   GO; GO:0030838; P:positive regulation of actin filament polymerization; ISO:RGD.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; IMP:RGD.
DR   GO; GO:0043507; P:positive regulation of JUN kinase activity; IDA:RGD.
DR   GO; GO:0043406; P:positive regulation of MAP kinase activity; IDA:RGD.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IDA:RGD.
DR   GO; GO:0050434; P:positive regulation of viral transcription; IDA:RGD.
DR   GO; GO:0046777; P:protein autophosphorylation; IDA:RGD.
DR   GO; GO:0006468; P:protein phosphorylation; IDA:RGD.
DR   GO; GO:0000209; P:protein polyubiquitination; IMP:RGD.
DR   GO; GO:0030334; P:regulation of cell migration; ISO:RGD.
DR   GO; GO:0006970; P:response to osmotic stress; IMP:RGD.
DR   GO; GO:0007179; P:transforming growth factor beta receptor signaling pathway; ISO:RGD.
DR   GO; GO:0006511; P:ubiquitin-dependent protein catabolic process; IGI:RGD.
DR   GO; GO:0042060; P:wound healing; ISO:RGD.
DR   Gene3D; 1.25.10.10; -; 1.
DR   Gene3D; 3.30.40.10; -; 1.
DR   InterPro; IPR011989; ARM-like.
DR   InterPro; IPR016024; ARM-type_fold.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   InterPro; IPR001841; Znf_RING.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   InterPro; IPR007527; Znf_SWIM.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF48371; SSF48371; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
DR   PROSITE; PS50089; ZF_RING_2; 1.
DR   PROSITE; PS50966; ZF_SWIM; 1.
PE   1: Evidence at protein level;
KW   Acetylation; ATP-binding; Kinase; Magnesium; Membrane; Metal-binding;
KW   Nucleotide-binding; Phosphoprotein; Reference proteome;
KW   Serine/threonine-protein kinase; Transferase; Zinc; Zinc-finger.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000250|UniProtKB:Q13233"
FT   CHAIN           2..1493
FT                   /note="Mitogen-activated protein kinase kinase kinase 1"
FT                   /id="PRO_0000086242"
FT   DOMAIN          1224..1489
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   ZN_FING         328..356
FT                   /note="SWIM-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00325"
FT   ZN_FING         433..482
FT                   /note="RING-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00175"
FT   NP_BIND         1230..1238
FT                   /note="ATP"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   COMPBIAS        25..29
FT                   /note="Poly-Gly"
FT   COMPBIAS        74..149
FT                   /note="Pro-rich"
FT   COMPBIAS        233..291
FT                   /note="Pro-rich"
FT   COMPBIAS        412..421
FT                   /note="Poly-Ser"
FT   COMPBIAS        1163..1168
FT                   /note="Poly-Glu"
FT   ACT_SITE        1350
FT                   /note="Proton acceptor"
FT   BINDING         1253
FT                   /note="ATP"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0000250|UniProtKB:Q13233"
FT   MOD_RES         21
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q13233"
FT   MOD_RES         137
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         265
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q13233"
FT   MOD_RES         275
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q13233"
FT   MOD_RES         282
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q13233"
FT   MOD_RES         287
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q13233"
FT   MOD_RES         290
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q13233"
FT   MOD_RES         497
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q13233"
FT   MOD_RES         521
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q13233"
FT   MOD_RES         910
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         999
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q13233"
FT   MOD_RES         1024
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q13233"
FT   MOD_RES         1381
FT                   /note="Phosphothreonine; by autocatalysis"
FT                   /evidence="ECO:0000269|PubMed:11784851"
FT   MOD_RES         1393
FT                   /note="Phosphothreonine; by autocatalysis"
FT                   /evidence="ECO:0000269|PubMed:11784851"
FT   MUTAGEN         1350
FT                   /note="D->N: Loss of kinase activity and of
FT                   autophosphorylation activity."
FT                   /evidence="ECO:0000269|PubMed:11784851"
FT   MUTAGEN         1369
FT                   /note="D->A: Inactivation."
FT                   /evidence="ECO:0000269|PubMed:8643568"
FT   MUTAGEN         1381
FT                   /note="T->A: Loss of kinase activity and activation by
FT                   autophosphorylation; when associated with T-1393."
FT                   /evidence="ECO:0000269|PubMed:11784851"
FT   MUTAGEN         1393
FT                   /note="T->A: Loss of kinase activity and activation by
FT                   autophosphorylation; when associated with T-1381."
FT                   /evidence="ECO:0000269|PubMed:11784851"
SQ   SEQUENCE   1493 AA;  161315 MW;  8C5F29F866898524 CRC64;
     MAAAAGDRAS SSGFPGAAAA SPEAGGGGGA LQGSGAPAAG AGLLRETGSA GRERADWRRQ
     QLRKVRSVEL DQLPEQPLFL TASPPCPSTS PSPEPADAAA GASGFQPAAG PPPPGAASRC
     GSHSAELAAA RDSGARSPAG AEPPSAAAPS GREMENKETL KGLHKMDDRP EERMIREKLK
     ATCMPAWKHE WLERRNRRGP VVVKPIPIKG DGSEMSNLAA ELQGEGQAGS AAPAPKGRRS
     PSPGSSPSGR SGKPESPGVR RKRVSPVPFQ SGRITPPRRA PSPDGFSPYS PEETSRRVNK
     VMRARLYLLQ QIGPNSFLIG GDSPDNKYRV FIGPQNCSCG RGTFCIHLLF VMLRVFQLEP
     SDPMLWRKTL KNFEVESLFQ KYHSRRSSRI KAPSRNTIQK FVSRMSNCHT LSSSSTSTSS
     SENSIKDEEE QMCPICLLGM LDEESLTVCE DGCRNKLHHH CMSIWAEECR RNREPLICPL
     CRSKWRSHDF YSHELSSPVD SPTSLRGVQQ PSSPQQPVAG SQRRNQESNF NLTHYGTQQI
     PPAYKDLAEP WIQAFGMELV GCLFSRNWNV REMALRRLSH DVSGALLLAN GESTGTSGGG
     SGGSLSAGAA SGSSQPSISG DVVEAFCSVL SIVCADPVYK VYVAALKTLR AMLVYTPCHS
     LAERIKLQRL LRPVVDTILV KCADANSRTS QLSISTLLEL CKGQAGELAV GREILKAGSI
     GVGGVDYVLS CILGNQAESN NWQELLGRLC LIDRLLLEIS AEFYPHIVST DVSQAEPVEI
     RYKKLLSLLA FALQSIDNSH SMVGKLSRRI YLSSARMVTT VPPLFSKLVT MLSASGSSHF
     ARMRRRLMAI ADEVEIAEVI QLGSEDTLDG QQDSSQALAP PRYPESSSLE HTAHVEKTGK
     GLKATRLSAS SEDISDRLAG VSVGLPSSAT TEQPKPTVQT KGRPHSQCLN SSPLSPPQLM
     FPAISAPCSS APSVPAGSVT DASKHRPRAF VPCKIPSASP QTQRKFSLQF QRTCSENRDS
     EKLSPVFTQS RPPPSSNIHR AKASRPVPGS TSKLGDASKN SMTLDLNSAS QCDDSFGSGS
     NSGSAVIPSE ETAFTPAEDK CRLDVNPELN SSIEDLLEAS MPSSDTTVTF KSEVAVLSPE
     KAESDDTYKD DVNHNQKCKE KMEAEEEEAL AIAMAMSASQ DALPIVPQLQ VENGEDIIII
     QQDTPETLPG HTKANEPYRE DTEWLKGQQI GLGAFSSCYQ AQDVGTGTLM AVKQVTYVRN
     TSSEQEEVVE ALREEIRMMS HLNHPNIIRM LGATCEKSNY NLFIEWMAGA SVAHLLSKYG
     AFKESVVINY TEQLLRGLSY LHENQIIHRD VKGANLLIDS TGQRLRIADF GAAARLASKG
     TGAGEFQGQL LGTIAFMAPE VLRGQQYGRS CDVWSVGCAI IEMACAKPPW NAEKHSNHLA
     LIFKIASATT APSIPSHLSP GLRDVALRCL ELQPQDRPPS RELLKHPVFR TTW
//
